Trevi Therapeutics

IPO

Passionate about Progress

Trevi Therapeutics was founded in 2011, is headquartered in New Haven, United States, lists 11–50 employees, and has $50.5M in recorded funding across 1 round.

Employees
11–50
Founded
2011
Total Funding
$50.5M
Last Round
$50.5M Series CAug 2017
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio™ (oral nalbuphine ER) to help patients suffering from chronic cough by targeting the central and peripheral cough reflex arc. The company has released positive Phase 2b results from its CORAL trial for chronic cough in idiopathic pulmonary fibrosis (IPF) and its Phase 2a RIVER trial for refractory chronic cough (RCC), and is now advancing toward Phase 3 trials. Founded in 2011 and headquartered in New Haven, Connecticut, Trevi is listed on NASDAQ under the ticker TRVI.

Summary

Trevi Therapeutics is a Healthcare company based in New Haven, United States, founded in 2011. It lists 11–50 employees. It has raised $50.5M in total across 1 round, most recently a $50.5M Series C round in Aug 2017. Investors include New Enterprise Associates.

Funding History

Series CSeries CAug 2017
$50.5M

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trevi Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/trevi-therapeutics"><img src="https://indexed.vc/api/badge/company/trevi-therapeutics" alt="Trevi Therapeutics on Indexed.vc" width="260" height="76" /></a>